US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alder BioPharmaceuticals

18.88

0.0000

Volume:- -

Turnover:- -

Market Cap:1.58B

PE:-4.29

High:18.88

Open:18.88

Low:18.88

Close:18.88

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Alder BioPharmaceuticals

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.alderbio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The companys lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperplasia and Cushings diseases; and Clazakizumab, an antibody that has been completed Phase II b clinical trial, which inhibits the pro-inflammatory cytokine interleukin-6 for the treatment of rheumatoid and psoriatic arthritis. In addition, the company has preclinical programs in the discovery phase for various indications. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALDR/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALDR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALDR\",,,,,undefined,":{"symbol":"ALDR","market":"US","secType":"STK","nameCN":"Alder BioPharmaceuticals","latestPrice":18.88,"timestamp":1571688000000,"preClose":18.88,"halted":3,"volume":0,"delay":0,"floatShares":70076818,"shares":83836702,"eps":-4.4042,"marketStatus":"Halted","change":0,"latestTime":"10-21 16:00:00 EDT","open":18.88,"high":18.88,"low":18.88,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.4042,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1399521600000,"exchange":"NASDAQ","adjPreClose":18.88,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALDR\",,,,,undefined,":{"symbol":"ALDR","floatShares":70076818,"roa":"-40.94%","roe":"-113.83%","lyrEps":-4.874278,"shares":83836702,"dividePrice":0,"high":18.88,"amplitude":0,"preClose":18.88,"low":18.88,"week52Low":8.39,"pbRate":"14.35","week52High":19.12,"institutionHeld":0,"latestPrice":18.88,"eps":-4.4042,"divideRate":0,"volume":0,"delay":0,"ttmEps":-4.4042,"open":18.88,"prevYearClose":18.88},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.alderbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The companys lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperplasia and Cushings diseases; and Clazakizumab, an antibody that has been completed Phase II b clinical trial, which inhibits the pro-inflammatory cytokine interleukin-6 for the treatment of rheumatoid and psoriatic arthritis. In addition, the company has preclinical programs in the discovery phase for various indications. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.","exchange":"NASDAQ","name":"Alder BioPharmaceuticals","nameEN":"Alder BioPharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALDR\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALDR\",params:#limit:5,,,undefined,":[{"date":"2019-08-06","symbol":"ALDR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.99,"defaultRemindTime":1565121600000,"name":null,"time":"Post Market","dateTimestamp":1565064000000,"actualEps":-1.04},{"market":"US","date":"2019-05-02","symbol":"ALDR","fiscalQuarterEnding":"2019/03","expectedEps":-1.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1556769600000,"reportTimeType":"post","actualEps":-1.63},{"market":"US","date":"2019-02-25","symbol":"ALDR","fiscalQuarterEnding":"2018/12","expectedEps":-1.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1551070800000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2018-11-05","symbol":"ALDR","fiscalQuarterEnding":"2018/09","expectedEps":-1.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1541394000000,"reportTimeType":"post","actualEps":-0.91},{"market":"US","date":"2018-08-07","symbol":"ALDR","fiscalQuarterEnding":"2018/06","expectedEps":-1.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1533614400000,"reportTimeType":"post","actualEps":-1.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALDR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALDR\",market:\"US\",delay:false,,,undefined,":{}}}